3 天
AZoLifeSciences on MSNGene Delivery Systems: Viral vs. Non-Viral VectorsThis article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...
BioViva’s journey in gene therapy began with its use of an adeno-associated virus (AAV) vector. The company’s lead gene therapy, BV-702, is AAV-based and is in preclinical development for ...
LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...
The genome of the Javan horseshoe bat ( Rhinolophus affinis ), a carrier of coronaviruses closely related to SARS-CoV-2, was also sequenced by the international research team. Credit: Burton Lim, ...
In summary, enalapril significantly mitigated multiple pathological markers associated with aging, including lipid droplets, amyloid, glycogen deposition, and fibrosis, in the brain, kidneys, liver, ...
Feb. 6, 2025 — Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life ...
It seeks to understand the process of trait inheritance from parents to offspring, including the molecular structure and function of genes, gene behaviour in the context of a cell or organism (e.g ...
Oxytocin receptor (Oxtr) signaling influences complex social behaviors in diverse species, including social monogamy in prairie voles. How Oxtr regulates specific components of social attachment ...
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent loss disorders, today announces ...
A new study reveals that sexual partners exchange unique bacterial signatures, detectable even when DNA evidence is absent.
The following highlights showcase the most pivotal, innovative research published across multiple therapeutic areas in ...
Applied DNA Sciences Inc (NASDAQ:APDN) reported its financial results for the first quarter of fiscal year 2025, showcasing a notable increase in revenue but also highlighting ongoing challenges with ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果